Preeclampsia with Abnormal Liver Function Tests Is Associated with Cholestasis in a Subgroup of Cases

Hypertension in Pregnancy

Volumn 23, Issue 1, 2004, Pages 19-27

  Goulis, Dimitrios G ^a   Walker, Ian A L ^b   De Swiet, Michael ^a   Redman, Christopher W G ^c   Williamson, Catherine ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b WEXHAM PARK HOSPITAL   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Bile acids; Cholestasis; Liver; Preeclampsia

Indexed keywords

BILE ACID;

ADULT; ARTICLE; BILE ACID BLOOD LEVEL; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME ASSAY; FEMALE; FETUS OUTCOME; HUMAN; LIVER DISEASE; LIVER FUNCTION TEST; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PREECLAMPSIA; PRURITUS;

ADRENERGIC ALPHA-AGONISTS; ADULT; ANTI-INFLAMMATORY AGENTS; BILE ACIDS AND SALTS; BIOLOGICAL MARKERS; BLOOD PLATELETS; CALCIUM CHANNEL BLOCKERS; CHOLESTASIS; DEXAMETHASONE; FEMALE; GREAT BRITAIN; HUMANS; LIVER FUNCTION TESTS; MATERNAL WELFARE; METHYLDOPA; NIFEDIPINE; PRE-ECLAMPSIA; PREGNANCY; TREATMENT OUTCOME;

EID: 1842532499     PISSN: 10641955     EISSN: None     Source Type: Journal    
DOI: 10.1081/PRG-120028278     Document Type: Article

References (38)

1. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161:1200-1204.
2. Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341:1447-1451.
3. Knapen MF, Mulder TP, Bisseling JG, Penders RH, Peters WH, Steegers EA. Plasma glutathione S-transferase alpha 1-1: a more sensitive marker for hepatocellular damage than serum alanine aminotransferase in hypertensive disorders of pregnancy. Am J Obstet Gynecol 1998; 178:161-165.
4. Reid R, Ivey KJ, Rencoret RH, Storey B. Fetal complications of obstetric cholestasis. BMJ 1976; 1:870-872.
5. Reyes H. The enigma of intrahepatic cholestasis of pregnancy: lessons from Chile. Hepatology 1982; 2:87-96.
6. Fisk NM, Storey GNB. Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 1988; 95:1137-1143.
7. Rioseco AJ, Ivankovic M, Manzur A, Hamed F, Kato SR, Parer JT, Germain AM. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994; 170:890-895.
8. Laatikainen T, Ikonen E. Serum bile acids in cholestasis of pregnancy. Obstet Gynecol 1977; 50:313-318.
9. Sjovall K, Sjovall J. Serum bile acid levels in pregnancy with pruritus. Clin Chim Acta 1965; 13:207-211.
10. Heikkinen J, Maentausta O, Ylostalo P, Janne O. Changes in serum bile acid concentrations during normal pregnancy, in patients with intrahepatic cholestasis of pregnancy and in pregnant women with itching. Br J Obstet Gynaecol 1981; 88:240-245.
11. Laatikainen T, Hesso A. Determination of serum bile acids by glass capillary gas-liquid chromatography. Clin Chim Acta 1975; 64:63-68.
12. Lunzer M, Barnes P, Byth K, O'Hallofan M. Serum bile acid concentrations during pregnancy and their relationship to obstetric cholestasis. Gastroenterology 1986; 91:825-829.
13. Heikkinen J, Maentausta O, Tuimala R, Ylostalo P, Janne O. Amniotic fluid bile acids in normal and pathologic pregnancy. Obstet Gynecol 1986; 56:60-64.
14. Girling JC, Dow E, Smith JH. Liver function tests in pre-eclampsia: importance of comparison with a reference range derived for normal pregnancy. Br J Obstet Gynaecol 1997; 104:246-250.
15. Mashige F, Tanaka N, Maki A, Kamei S, Yamanaka M. Direct spectrophotometry of total bile acids in serum. Clin Chem 1981; 27:1352-1356.
16. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol 1990; 162:311-316.
17. Oosterhof H, Voorhoeve PG, Aarnoudse JG. Enhancement of hepatic artery resistance to blood flow in pre-eclampsia in presence or absence of HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets). Am J Obstet Gynecol 1994; 171:526-530.
18. Ibdah JA, Bennett MJ, Rinaldo P, Zhao Y, Gibson B, Sims HF, Strauss AW. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999; 340:1723-1731.
19. Tyni T, Ekholm E, Pihko H. Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Obstet Gynecol 1998; 178:603-608.
20. Kreek MJ, Weser E, Sleisenger MH, Jeffries GH. Idiopathic cholestasis of pregnancy: the response to challenge with the synthetic estrogen, ehtinyl estradiol. N Engl J Med 1967; 277:1391-1395.
21. Holzbach RT, Sivak DA, Braun WE. Familial recurrent intrahepatic cholestasis of pregnancy: a genetic study providing evidence for transmission of a sex-limited, dominant trait. Gastroenterology 1983; 85:175-179.
22. Bacq Y, Sapey T, Brechot MC, Pierre F, Fignon A, Dubois F. Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology 1997; 26:358-364.
23. Jacquemin E, Cresteil D, Manouvrier S, Boute O, Hadchouel M. Heterozygous nonsense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999; 353:210-211.
24. Dixon PH, Weerasekera N, Linton KJ, Donaldson O, Chambers J, Egginton E, Weaver J, Nelson-Piercy C, de Swiet M, Warnes G, Elias E, Higgins CF, Johnston DG, McCarthy MI, Williamson C. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 2000; 9:1209-1217.
25. Simon FR, Fortune J, Iwahashi M, Gartung C, Wolkoff A, Sutherland E. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am J Physiol 1996; 271:G1043-G1052.
26. +-ATPase and bile flow by estrogen: effects on liver surface membrane lipid structure and function. Proc Natl Acad Sci U S A 1978; 75:4130-4134.
27. Simon FR, Gonzalez M, Sutherland E, Accatino L, Davis RA. Reversal of ethinyl estradiol-induced bile secretory failure with Triton WR-1339. J Clin Invest 1980; 65:851-860.
28. Perreau P, Rouchy R. Ictere cholestatique recidivant de la grossesse. Gynecol Obstet 1961; 60:161-179.
29. Berg B, Helm G, Petersohn I, Tryding N. Cholestasis of pregnancy. Clinical and laboratory studies. Acta Obstet Gynecol Scand 1986; 65:107-113.
30. Reyes H, Gonzalez MC, Ribalta J. Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Intern Med 1978; 88:487-493.
31. Kenyon AP, Nelson-Piercy C, Girling J, Williamson C, Tribe RM, Shennan AH. Obstetric cholestasis, outcome with active management: a series of 70 cases. Br J Obstet Gynaecol 2002; 109:282-288.
32. Korman MG, Hofmann AF, Summerskill WHJ. Assessment of activity in chronic active liver disease: serum bile acids compared with conventional tests and histology. N Engl J Med 1974; 290:1399-1402.
33. Hofmann AF, Korman MG, Krugman S. Sensitivity of serum bile acid assay for detection of liver damage in viral hepatitis type B: prospective study in five patients. Dig Dis 1974; 19:908-910.
34. Bouchier IAD, Pennington CR. Serum bile acids in hepatobiliary disease. Gut 1978; 19:492-496.
35. Miescher G, Paumgartner G, Preisig R. Portal-systemic spill-over of bile acids: a study of mechanisms using ursodeoxycholic acid. Eur J Clin Investig 1983; 13:439-445.
36. Vierling JM, Berk PD, Hofmann AF, Martin JF, Wolkoff AW, Scharschmidt BF. Normal fasting-state levels of serum cholyl-conjugated bile acids in Gilbert's syndrome: an aid to the diagnosis. Hepatology 1982; 2:340-343.
37. Toghill PJ, Smith PG, Benton P, Brown RC, Matthews HL. Methyldopa liver damage. BMJ 1974; 3:545-548.
38. Rodman JS, Deutsch DJ, Gutman SI. Methyldopa hepatitis: a report of six cases and review of the literature. Am J Med 1976; 60:941-948.